351 related articles for article (PubMed ID: 33763059)
1. Arrest in the Progression of Type 1 Diabetes at the Mid-Stage of Insulitic Autoimmunity Using an Autoantigen-Decorated All-
Phillips BE; Garciafigueroa Y; Engman C; Liu W; Wang Y; Lakomy RJ; Meng WS; Trucco M; Giannoukakis N
Front Immunol; 2021; 12():586220. PubMed ID: 33763059
[TBL] [Abstract][Full Text] [Related]
2. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
[TBL] [Abstract][Full Text] [Related]
3. Orally delivered all-trans-retinoic acid- and transforming growth factor-β-loaded microparticles ameliorate type 1 diabetes in mice.
Koprivica I; Gajic D; Saksida T; Cavalli E; Auci D; Despotovic S; Pejnovic N; Stosic-Grujicic S; Nicoletti F; Stojanovic I
Eur J Pharmacol; 2019 Dec; 864():172721. PubMed ID: 31586630
[TBL] [Abstract][Full Text] [Related]
4. Immunomodulatory Dual-Sized Microparticle System Conditions Human Antigen Presenting Cells Into a Tolerogenic Phenotype
Brusko MA; Stewart JM; Posgai AL; Wasserfall CH; Atkinson MA; Brusko TM; Keselowsky BG
Front Immunol; 2020; 11():574447. PubMed ID: 33193362
[TBL] [Abstract][Full Text] [Related]
5. A Novel Liposome Formulation Carrying Both an Insulin Peptide and a Ligand for Invariant Natural Killer T Cells Induces Accumulation of Regulatory T Cells to Islets in Nonobese Diabetic Mice.
Akimoto H; Fukuda-Kawaguchi E; Duramad O; Ishii Y; Tanabe K
J Diabetes Res; 2019; 2019():9430473. PubMed ID: 31781669
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast Cell-Based Therapy for Experimental Autoimmune Diabetes.
Jalili RB; Zhang Y; Hosseini-Tabatabaei A; Kilani RT; Khosravi Maharlooei M; Li Y; Salimi Elizei S; Warnock GL; Ghahary A
PLoS One; 2016; 11(1):e0146970. PubMed ID: 26765526
[TBL] [Abstract][Full Text] [Related]
7. Reversal of New Onset Type 1 Diabetes by Oral
Mbongue JC; Rawson J; Garcia PA; Gonzalez N; Cobb J; Kandeel F; Ferreri K; Husseiny MI
Front Immunol; 2019; 10():320. PubMed ID: 30863412
[TBL] [Abstract][Full Text] [Related]
8. Factors affecting Salmonella-based combination immunotherapy for prevention of type 1 diabetes in non-obese diabetic mice.
Husseiny MI; Du W; Mbongue J; Lenz A; Rawson J; Kandeel F; Ferreri K
Vaccine; 2018 Dec; 36(52):8008-8018. PubMed ID: 30416020
[TBL] [Abstract][Full Text] [Related]
9. KLRG1 expression identifies short-lived Foxp3
Kornete M; Mason E; Istomine R; Piccirillo CA
Autoimmunity; 2017 Sep; 50(6):354-362. PubMed ID: 28850267
[TBL] [Abstract][Full Text] [Related]
10. Autoantigen-specific TGFbeta-induced Foxp3+ regulatory T cells prevent autoimmunity by inhibiting dendritic cells from activating autoreactive T cells.
DiPaolo RJ; Brinster C; Davidson TS; Andersson J; Glass D; Shevach EM
J Immunol; 2007 Oct; 179(7):4685-93. PubMed ID: 17878367
[TBL] [Abstract][Full Text] [Related]
11. An Insulin-Inspired Supramolecular Hydrogel for Prevention of Type 1 Diabetes.
Liu M; Wang Z; Feng D; Shang Y; Li X; Liu J; Li C; Yang Z
Adv Sci (Weinh); 2021 May; 8(10):2003599. PubMed ID: 34026440
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of TGF-βRII in T effector cells leads to increased resistance to TGF-β-mediated suppression of autoimmune responses in type I diabetes.
Kawamoto K; Pahuja A; Nettles A; Honkanen-Scott M; Bansal-Pakala P
Autoimmunity; 2012 Jun; 45(4):310-9. PubMed ID: 22390157
[TBL] [Abstract][Full Text] [Related]
13. Single cell analysis shows decreasing FoxP3 and TGFbeta1 coexpressing CD4+CD25+ regulatory T cells during autoimmune diabetes.
Pop SM; Wong CP; Culton DA; Clarke SH; Tisch R
J Exp Med; 2005 Apr; 201(8):1333-46. PubMed ID: 15837817
[TBL] [Abstract][Full Text] [Related]
14. Tracking of an Oral
Mbongue JC; Alhoshani A; Rawson J; Garcia PA; Gonzalez N; Ferreri K; Kandeel F; Husseiny MI
Front Immunol; 2020; 11():712. PubMed ID: 32411136
[TBL] [Abstract][Full Text] [Related]
15. Use of autoantigen-loaded phosphatidylserine-liposomes to arrest autoimmunity in type 1 diabetes.
Pujol-Autonell I; Serracant-Prat A; Cano-Sarabia M; Ampudia RM; Rodriguez-Fernandez S; Sanchez A; Izquierdo C; Stratmann T; Puig-Domingo M; Maspoch D; Verdaguer J; Vives-Pi M
PLoS One; 2015; 10(6):e0127057. PubMed ID: 26039878
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune diabetes is suppressed by treatment with recombinant human tissue Kallikrein-1.
Maneva-Radicheva L; Amatya C; Parker C; Ellefson J; Radichev I; Raghavan A; Charles ML; Williams MS; Robbins MS; Savinov AY
PLoS One; 2014; 9(9):e107213. PubMed ID: 25259810
[TBL] [Abstract][Full Text] [Related]
17. Self-Transducible Bimodal PDX1-FOXP3 Protein Lifts Insulin Secretion and Curbs Autoimmunity, Boosting Tregs in Type 1 Diabetic Mice.
Amatya C; Radichev IA; Ellefson J; Williams M; Savinov AY
Mol Ther; 2018 Jan; 26(1):184-198. PubMed ID: 28988715
[TBL] [Abstract][Full Text] [Related]
18. Plant-based vaccines for oral delivery of type 1 diabetes-related autoantigens: Evaluating oral tolerance mechanisms and disease prevention in NOD mice.
Posgai AL; Wasserfall CH; Kwon KC; Daniell H; Schatz DA; Atkinson MA
Sci Rep; 2017 Feb; 7():42372. PubMed ID: 28205558
[TBL] [Abstract][Full Text] [Related]
19. Antigen Loading (e.g., Glutamic Acid Decarboxylase 65) of Tolerogenic DCs (tolDCs) Reduces Their Capacity to Prevent Diabetes in the Non-Obese Diabetes (NOD)-Severe Combined Immunodeficiency Model of Adoptive Cotransfer of Diabetes As Well As in NOD Mice.
Funda DP; Goliáš J; Hudcovic T; Kozáková H; Špíšek R; Palová-Jelínková L
Front Immunol; 2018; 9():290. PubMed ID: 29503651
[TBL] [Abstract][Full Text] [Related]
20. Multiple mechanisms involved in diabetes protection by lipopolysaccharide in non-obese diabetic mice.
Wang J; Cao H; Wang H; Yin G; Du J; Xia F; Lu J; Xiang M
Toxicol Appl Pharmacol; 2015 Jun; 285(3):149-58. PubMed ID: 25896969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
